A sponsor-underwriting guide to private equity in gastroenterology, covering platform and add-on roles, earnings quality, regulated growth, financing, rollover governance, downside returns, and seller liquidity.
A buyer-landscape guide to gastroenterology practice acquirers, covering overlapping buyer models, platform examples, physician succession, facility interests, financing, integration, and offer certainty.
A transaction-focused guide to gastroenterology practice M&A covering GI group economics, endoscopy exposure, buyer underwriting, diligence, financing, and seller outcomes.
A transaction-focused guide to vision care M&A, connecting optometry and ophthalmology revenue quality, optical retail, surgical exposure, referrals, payer mix, buyer underwriting, financing, and seller outcomes.
A buyer-landscape guide to eye care practice acquirers, including strategic platforms, private equity-backed groups, MSOs, physician buyers, financing, diligence, integration risk, offer structure, and seller decision-making.
A sponsor-underwriting guide to private equity in eye care, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, optical and clinical economics, cash conversion, leverage, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
A transaction-focused guide to retina practice M&A, including specialist capacity, injection and procedure mix, buy-and-bill exposure, payer and referral durability, platform demand, diligence, valuation, and seller proceeds.
A seller-focused guide to selling a dermatology practice, including owner objectives, sale readiness, buyer-accepted earnings, provider and payer durability, Mohs and pathology economics, confidential buyer outreach, IOI and LOI comparison, diligence, working capital, seller proceeds, closing, and physician transition.
A buyer-landscape guide to dermatology practice acquirers, including strategic groups, private equity-backed platforms, MSOs, physician buyers, health systems, buyer eligibility, operating fit, financing certainty, diligence, integration risk, offer structure, and seller decision-making.
A sponsor-underwriting guide to private equity in dermatology, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, Mohs and pathology economics, payer and referral durability, cash conversion, leverage, financing, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.